NO20052534L - Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer - Google Patents

Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer

Info

Publication number
NO20052534L
NO20052534L NO20052534A NO20052534A NO20052534L NO 20052534 L NO20052534 L NO 20052534L NO 20052534 A NO20052534 A NO 20052534A NO 20052534 A NO20052534 A NO 20052534A NO 20052534 L NO20052534 L NO 20052534L
Authority
NO
Norway
Prior art keywords
antibacterial agents
isocazoline
oxazolidinone
derivatives
het
Prior art date
Application number
NO20052534A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052534D0 (no
Inventor
Michael Barry Gravestock
Neil James Hales
Sheila Irene Hauck
Daniel Robert Carcanague
Thomas Peter Weber
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227702A external-priority patent/GB0227702D0/en
Priority claimed from GB0304725A external-priority patent/GB0304725D0/en
Priority claimed from GB0318608A external-priority patent/GB0318608D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20052534D0 publication Critical patent/NO20052534D0/no
Publication of NO20052534L publication Critical patent/NO20052534L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20052534A 2002-11-28 2005-05-26 Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer NO20052534L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0227702A GB0227702D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0304725A GB0304725D0 (en) 2003-03-01 2003-03-01 Chemical compounds
GB0318608A GB0318608D0 (en) 2003-08-08 2003-08-08 Chemical compounds
PCT/GB2003/005087 WO2004048392A1 (en) 2002-11-28 2003-11-24 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents

Publications (2)

Publication Number Publication Date
NO20052534D0 NO20052534D0 (no) 2005-05-26
NO20052534L true NO20052534L (no) 2005-08-22

Family

ID=32397650

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052534A NO20052534L (no) 2002-11-28 2005-05-26 Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer

Country Status (15)

Country Link
US (1) US20060116400A1 (enExample)
EP (1) EP1567532A1 (enExample)
JP (1) JP2006508192A (enExample)
KR (1) KR20050085193A (enExample)
AU (1) AU2003302404B2 (enExample)
BR (1) BR0316688A (enExample)
CA (1) CA2507468A1 (enExample)
HK (1) HK1079794A1 (enExample)
IL (1) IL168747A0 (enExample)
MX (1) MXPA05005651A (enExample)
NO (1) NO20052534L (enExample)
NZ (1) NZ540147A (enExample)
SA (1) SA04250088A (enExample)
TW (1) TW200533666A (enExample)
WO (1) WO2004048392A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1427711E (pt) * 2001-09-11 2005-11-30 Astrazeneca Ab Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
NZ535591A (en) 2002-02-28 2006-07-28 Astrazeneca Ab Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
WO2004048350A2 (en) 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
AU2004267007C1 (en) 2003-06-03 2010-04-29 Melinta Subsidiary Corp. Biaryl heterocyclic compounds and methods of making and using the same
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
JP4777246B2 (ja) * 2003-07-29 2011-09-21 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ビアリールオキサゾリジノンの合成方法
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
MXPA06013540A (es) * 2004-05-25 2007-01-26 Astrazeneca Ab Derivados de 3-(4-(2 -dihidroisoxasol -3-ilpiridin-5-il) fenil)-5- triazol-1- ilmetiloxazolidin -2-ona como inhibidores de mao para el tratamiento de infecciones bacterianas.
US20080064689A1 (en) * 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
WO2010042887A2 (en) * 2008-10-10 2010-04-15 Trius Therapeutics Methods for preparing oxazolidinones and compositions containing them
BRPI1008829A2 (pt) 2009-02-03 2016-03-15 Trius Therapeutics forma cristalina de dihidrogenofosfato de (r)-3-(4-(2-(2-metiltetrazol-5-il) piridin-5-il)-3-fluorofenil)-5-hidroximetil oxazolidin-2-ona
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
WO2013091836A1 (en) * 2011-12-19 2013-06-27 Saudi Basic Industries Corporation (Sabic) Process for the preparation of metallocene complexes
CN104080792A (zh) * 2011-12-19 2014-10-01 沙特基础工业公司 用于制备茂金属络合物的方法
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
WO2021000297A1 (en) 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents
CN113149924B (zh) * 2021-03-29 2023-11-03 苏州大学 一种异噁唑啉的简单制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
PT1427711E (pt) * 2001-09-11 2005-11-30 Astrazeneca Ab Derivados de oxazolidinona e/ou isoxazolina como agentes antibacterianos
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
TW200533666A (en) 2005-10-16
AU2003302404A1 (en) 2004-06-18
US20060116400A1 (en) 2006-06-01
WO2004048392A1 (en) 2004-06-10
MXPA05005651A (es) 2005-07-27
AU2003302404B2 (en) 2008-06-19
SA04250088A (ar) 2005-12-03
CA2507468A1 (en) 2004-06-10
NO20052534D0 (no) 2005-05-26
IL168747A0 (en) 2009-02-11
JP2006508192A (ja) 2006-03-09
EP1567532A1 (en) 2005-08-31
KR20050085193A (ko) 2005-08-29
NZ540147A (en) 2008-03-28
HK1079794A1 (zh) 2006-04-13
BR0316688A (pt) 2005-10-18

Similar Documents

Publication Publication Date Title
NO20053133L (no) Kjemiske forbindelser.
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
WO2006034446A3 (en) Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
WO2006034440A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
DE60317326D1 (de) Phenylalkansäure- und phenyloxyalkansäure-derivate als hppar aktivatore
WO2004016578A8 (en) Arylethanolamine beta2-adrenoreceptor agonist compounds
HK1079794A1 (zh) 用作抗菌药物的恶唑烷酮和/或异恶唑啉衍生物
MX2007003319A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
NO20070944L (no) Pellet formulering med forlenget frigjoring inneholdende pramipexol eller et farmasoytiskakseptabelt salt derav, fremgangsmate forfremstilling og anvendelse derav
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
SG171471A1 (en) New benzimidazole derivatives
AU2003237955A8 (en) Phenyloxyalkanonic acid derivatives as hppar activators
NO20061839L (no) Benzimidazolderivater, sammensetninger inneholdende dem, fremstilling derav, og anvendelse derav
JO2413B1 (en) Benzoxazine derivatives and their use
WO2000068198A3 (en) Heterosubstituted pyridine derivatives as pde 4 inhibitors
GB0205688D0 (en) Chemical compounds
WO2006067392A3 (en) Indole derivatives for the treatment of tuberculosis
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
MXPA05007923A (es) Derivados de monosacaridos de avermectina que tienen propiedades pesticidas.
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2004083185A3 (en) Phenyl substituted imidazole derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application